United States · Markets & Finance · The Wall Street Journal

How a Top Diabetes Nonprofit Reined In Its Venture-Capital Arm

Published by The Wall Street Journal · United States 12 h ago

The venture arm of diabetes research nonprofit Breakthrough T1D was ramping up its efforts to raise $150 million to propel new treatments to market when its leadership collapsed…

Read the full article on The Wall Street Journal Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.wsj.com)

Also worth reading

Seeking Alpha

Investors thought they were buying pre-IPO OpenAI and SpaceX shares. Their cash went to strip clubs, Bloomingdale’s, and shopping on Amazon, SEC alleges

Business Insider

Read the letter Trump is sending along with $500 checks to nearly 1 million Americans for ACA 'refunds'

OilPrice.com

How a Top Diabetes Nonprofit Reined In Its Venture-Capital Arm

Share

Also worth reading

Thursday’s Economic Calendar

Trump’s New Tariffs Get a Familiar Day in Court

CFTC seeks to define event contracts as swaps amid prediction market fight

Investors thought they were buying pre-IPO OpenAI and SpaceX shares. Their cash went to strip clubs, Bloomingdale’s, and shopping on Amazon, SEC alleges

Read the letter Trump is sending along with $500 checks to nearly 1 million Americans for ACA 'refunds'

Iran’s Disappearing Oil Is Becoming Everyone’s Problem